A novel drug candidate can prevent nerve cell damage in a mouse model with Parkinson's disease. The drug protects nerve cells that produce dopamine, the chemical responsible for agility and movement that is lost in Parkinson's.
Study results show that physicians are underutilizing methotrexate, the leading drug for rheumatoid arthritis (RA), or not keeping patients on the drug long enough before switching them to more expensive biologic drug options.
Driving simulation and real-world data recording systems will shed light on brain health, functional abilities of people with neurological problems neurological disorders
New iPhone app from Apple is designed to make it easier for large numbers of HIV patients to participate in research. Will enable participants to easily complete tasks or submit surveys right from the app.
A new H1N1 vaccine is entering a definitive round of testing this month. Researchers hope to establish its ability to ward off the virus. If tests yield results as expected, hog farmers could begin using the new vaccine as early as the end of the year.
In the last decade, there’s been an explosion in treating PAD using angioplasty and stenting – a minimally invasive procedure in which the patient is awake and usually leaves the hospital the next day. Stents, small tubular metal devices that doctors put in diseased arteries to keep them open, work well in the heart, but often fail miserably in the leg arteries. Though peripheral artery disease stents may generally work for many patients, there is significant room for improvement as many patients require repeat procedures in as little as one or two years, said Jason MacTaggart, M.D. A national study estimated the cost at $21 billion a year.
Lung cancer patients with comorbid conditions such as chronic obstructive pulmonary disease, diabetes, or congestive heart failure have a higher risk of death than lung cancer patients without comorbid conditions. The prevalence of these comorbidities is higher in older lung cancer patients than patients who are younger. As the population of the United States ages, there will be a higher number of lung cancer patients with comorbidities at diagnosis. An estimated 74 percent of patients have one or more comorbidities. More than 50 percent of those with comorbidities had pulmonary disease, while 16 percent had diabetes, and 13 percent had congestive heart failure.
The focus will be on Ebola genomics and the study of the next generation of DNA sequencing technologies used to study the disease.
An innovative training program at the University of Nebraska Medical Center using lightly embalmed cadavers helps better prepare surgeons in training and serves as a national model. Lightly embalmed cadavers more realistically mimic actual surgeries and allow surgeons in training to walk before they run.
Over two and a half years, researchers will develop a formulation of a molecule called Butyrylcholinesterase (BChE) into an intramuscular injection, and prove its safety, effectiveness and dosing in animal models. They also will demonstrate its ability in dried form to retain activity for at least two years, and produce the substance for other research studies. BChE, which is found in human plasma, is a bioscavenger and when it finds nerve agent in the blood, it deactivates it. Following successful results, researchers will seek Food and Drug Administration approval followed by commercial production. Once research is complete, making it available for commercial use could take two to four years.
Denham Harman, M.D., Ph.D., the man who correctly theorized that free radicals cause aging and that antioxidants can reduce the effects of free radicals, died Tuesday at the age of 98.
The five-year grant was awarded by the U.S. Department of Health and Human Services’ Agency for Healthcare Research and Quality (AHRQ) to measure best practices across existing EHR systems, listen and learn what providers believe to be the ideal system, then build and test a model EHR system that can improve patient care.
Two, free online Ebola education downloadable courses will provide easy-to-understand instruction and resources for health care professionals, as well as the general public.
The Omaha study will look at diseases unfamiliar to most people.
A University of Nebraska Medical Center research team has determined that a longtime antibiotic, vancomycin, is still effective in treating Staphylococcus aureus bloodstream infections and that physicians should continue to use the drug even though several newer antibiotics are now available in the marketplace.
National conference to explore role of physician assistants in meeting challenges of rural health care
Since 1993, the profile of a drugged driver has changed substantially. A study released today in Public Health Reports shows that more drivers are now testing positive for prescription drugs, cannabis, and multiple drugs, and they are more likely to be older than 50.
A study by researchers at the University of Nebraska Medical Center shows vitamin D as an add-on therapy could provide some relief for chronic hives, a condition with no cure and few treatment options.
Thanks to a partnership between the University of Nebraska Medical Center and Ferris State University getting tested and treated for the flu and strep throat is now as convenient as a trip to the grocery store.
In a move to reduce health care associated infections, certain attire for health care professionals, including the traditional white coat, could become a thing of the past.
RSS
Medicine keyboard_arrow_right
Sciencekeyboard_arrow_right
Life keyboard_arrow_right
Business keyboard_arrow_right
Journal News keyboard_arrow_right
By Location keyboard_arrow_right
Meetings, Grants, and Events keyboard_arrow_right